About the designer filler

The Teoxane RHA® Collection is dynamically different.

A RHA Collection patient's face puckered to show the dynamic facial filler.

Designed for facial dynamics

Your face is dynamic—making millions of movements. Repetitive movements like laughing and talking create facial lines called dynamic wrinkles and folds.

Because these areas are mobile, treating facial lines can be difficult. Sometimes fillers can make the treated area look stiff and unnatural when the face is moving.

The Teoxane RHA® Collection is different. It is designed to be resilient enough to adapt to your dynamic facial movements for a look that’s beautiful at rest and flawless in motion.

The Teoxane RHA® Collection patient smiling to show the natural look of the filler.

Designed for a natural look

Your skin naturally contains hyaluronic acid (HA), which provides moisture, volume, and structure that help it appear smooth and refreshed. Your skin produces less HA over time as we age.

The Teoxane RHA® Collection uses a gentle manufacturing process to help preserve the natural structure of HA—allowing it to more closely resemble the HA in your skin—for clean beauty.

A collection for your different dynamic needs

These long-lasting fillers can last up to 15 months in dynamic wrinkles and folds and 1 year in lipstick lines. Your provider will customize a treatment plan for your desired goals.

Clinical effectiveness and safety was demonstrated in two 15-month clinical trials for the treatment of moderate to severe nasolabial folds. For dynamic lipstick lines, 2/3 of people still saw noticeable results at one year.

RHA Redensity™

A RHA Redensity patient using a straw to demonstrate the filler.

Weightless filler that smooths delicate lipstick lines.

RHA® 2 and RHA® 3

A RHA Redensity patient using a straw to demonstrate the filler.

Elegant and refined smoothing for those seeking a soft, natural look.

RHA® 4

A patient with RHA 4 to show natural volume of the facial filler.

Natural volume for deeper dynamic wrinkles and folds.

See the dynamic difference in the before & afters and find an exclusive provider near you.

The Teoxane RHA® Collection explains filler history

Outlined icon
1893
The first dermal filler injection using autologous fat.
Outlined icon
1989
The first hyaluronic acid dermal filler was developed.
Outlined icon
2000
The first hyaluronic acid dermal filler technology is created and approved to address facial wrinkles and folds.
Outlined icon
2003
The beginning of the hyaluronic acid dermal filler era.
Outlined icon
2015
The Teoxane RHA® Collection was launched in Europe.
Outlined icon
2020
The Teoxane RHA® Collection of dermal fillers is made available in the U.S.—the latest innovation in hyaluronic acid fillers.

Beauty Blog

Seeing is believing

10/11/2022

Seeing is believing

Spot the difference between Aimiende's before-and-after images when she was treated with the Teoxane RHA® Collection.

Beauty is dynamic. Your filler should be, too.

10/10/2022

Beauty is dynamic.
Your filler should be, too.

Did you know that not all dermal fillers are the same? Learn how the Teoxane RHA® Collection is different.

Experience the Teoxane RHA® Collection

Teoxane RHA® Collection of Fillers

Approved Uses
The RHA® Collection of resilient hyaluronic acid (HA) fillers includes RHA Redensity™, RHA® 2, RHA® 3 and RHA® 4.

RHA Redensity™ is for injection into the facial tissue for the correction of moderate to severe dynamic perioral rhytids; and RHA® 2 and RHA® 4 are for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds, in adults 22 or older. RHA® 3 is for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds, and also used to augment lip fullness in adults 22 or older.

IMPORTANT SAFETY INFORMATION

Are there any reasons why I should not receive any RHA® injectable gel formulation?
Do not receive if you have a history of multiple severe allergies or severe allergic reactions; if you are allergic to lidocaine or gram-positive bacterial proteins; or if you have a bleeding disorder.

What precautions should I discuss with my doctor?
• Tell your doctor if you are pregnant or breastfeeding as the safety of these products for use during pregnancy or while breastfeeding has not been studied
• Tell your doctor if you have a history of excessive scarring, keloid formations or pigmentation disorders, as use of these products may result in additional scars or changes in pigmentation
• Tell your doctor if you are planning laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment
• Tell your doctor if you are on immunosuppressive therapy used to decrease your immune response, as use of these products may result in an increased risk of infection
• Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may increase bruising or bleeding at the injection site
• The safety and effectiveness of RHA® fillers in areas other than those indicated have not been established in U.S. clinical studies
• Patients who experience skin injury near the site of injection with this product may be at a higher risk for side effects
• Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment

What are possible side effects?
The most commonly reported side effects included injection-site redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching.

One of the risks with using these products is unintentional injection into a blood vessel, and while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.

Delayed-onset inflammation near the site of dermal filler injections is one of the known side effects associated with dermal fillers. Cases of delayed-onset inflammation have been reported to occur at the treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to being treated or resolved on its own.

As with all skin injection procedures, there is a risk of infection and recurrence of herpetic eruptions.

To report a side effect with any RHA® product, please call Revance at (877) 373-8669. Please visit RHACollection.com or talk to your doctor for more information.

RHA® is a registered trademark of TEOXANE SA, manufactured in Switzerland. The RHA® Collection is exclusively distributed by Revance Aesthetics™.

Available by prescription only.
RHA-P-002435.3

© 2024 Revance Aesthetics | All rights reserved.

2024 Shape® Skin Award logo ©2024 Meredith Operations Corporation, a Dotdash Meredith company. Used under license.

Revance Aesthetics and the Revance logo are trademarks of Revance Therapeutics, Inc. RHA® is a registered trademark of TEOXANE SA, manufactured in Switzerland. The RHA® Collection is exclusively distributed by Revance Aesthetics™. Redensity is a trademark of TEOXANE SA. All other trademarks are the property of their respective owners. RHA-00280 RHA00664